Home › NDC Lookup › RxCUI directory › RxCUI 1242240

Chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet — RxCUI 1242240

RxNorm drug concept · Semantic clinical drug
RxCUI 1242240 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1242240
Official nameChlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. The injection raises low blood pressure during anesthesia and, for some products, septic shock. Eye drops dilate the pupil, nasal products relieve conges...
  • Be careful. Over-the-counter phenylephrine should not be used with a prescription MAOI or within 2 weeks of stopping one. If you aren't sure whether your medicine is an MAOI, ask m...
  • With the injection, the most common are nausea, vomiting and headache. Call for help right away if you have chest pain, a very slow heartbeat, or pain or skin changes around the IV...
  • Stop and talk to a doctor if you get nervousness, dizziness or sleeplessness. Also stop if symptoms last more than 7 days or come with a fever. Don't use more than the label recomm...
📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How Chlorpheniramine maleate 2 MG / phenylephrine hy... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet RxCUI 1242240

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Chlorpheniramine 2400
    • Phenylephrine 8163
    • Chlorpheniramine / phenylephrine 214393
    • Chlorpheniramine maleate 142429
    • Phenylephrine hydrochloride 8164
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chlorpheniramine / phenylephrine Oral Tablet 371413
    • Chlorpheniramine maleate / phenylephrine hydrochloride Oral Tablet 2648137
    • Chlorpheniramine / phenylephrine Oral Product 1155123
    • Chlorpheniramine / phenylephrine Pill 1155124
    • Chlorpheniramine maleate / phenylephrine hydrochloride Oral Product 2662885
    • Chlorpheniramine maleate / phenylephrine hydrochloride Pill 2663324
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Chlorpheniramine maleate 2 MG 999433
    • Phenylephrine hydrochloride 5 MG 1020198

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chlorpheniramine maleate 2 MG SCDC · 999433
  • Phenylephrine hydrochloride 5 MG SCDC · 1020198
  • Chlorpheniramine / phenylephrine Oral Tablet SCDF · 371413
  • Chlorpheniramine maleate / phenylephrine hydrochloride Oral Tablet SCDFP · 2648137
  • Chlorpheniramine / phenylephrine Oral Product SCDG · 1155123
  • Chlorpheniramine / phenylephrine Pill SCDG · 1155124
  • Chlorpheniramine maleate / phenylephrine hydrochloride Oral Product SCDGP · 2662885
  • Chlorpheniramine maleate / phenylephrine hydrochloride Pill SCDGP · 2663324

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1242240 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49873-0109-01 4 BLISTER PACK in 1 CARTON (49873-109-01) / 6 TABLET in 1 B... Stonarhini Sato Pharmaceutical Co., Ltd. 2001-11-16
Observed labelers: Sato Pharmaceutical Co., Ltd. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.